INTERNATIONAL PATENT: SHANGHAI CHEMPARTNER PHARMACEUTICAL TECHNOLOGY CO., LTD., 上海睿智医药技术有限公司 FILES APPLICATION FOR "NEW ERIBULIN-RELATED ACTIVE MOLECULE, LINKER-DRUG TOXIN MOLECULE COMPOUND CONTAINING SAME AND USE THEREOF IN ANTIBODY CONJUGATE"

GENEVA, Feb. 23 -- SHANGHAI CHEMPARTNER PHARMACEUTICAL TECHNOLOGY CO., LTD. (No. 356 Longgui Road, Building 13, 1st FloorPudong New Area, Shanghai 201201), 上海睿智医药技术有限公司 (中国上海市浦东新区龙桂路356号第13幢1层) filed a patent application (PCT/CN2025/115081) for "NEW ERIBULIN-RELATED ACTIVE MOLECULE, LINKER-DRUG TOXIN MOLECULE COMPOUND CONTAINING SAME, AND USE THEREOF IN ANTIBODY CONJUGATE" on Aug 15, 2025. With publication no. WO/2026/037417, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted ...